Alzheimer's Disease

Showing NaN - NaN of 92

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial in United States (florbetapir F 18, Flortaucipir F18, Brain PET Scan)

Completed
  • Alzheimer's Disease
  • florbetapir F 18
  • +2 more
  • Phoenix, Arizona
  • +26 more
Sep 3, 2020

Alzheimer's Disease Trial in Australia, United States (Flortaucipir F18, PET Scan)

Completed
  • Alzheimer's Disease
  • Flortaucipir F18
  • PET Scan
  • Phoenix, Arizona
  • +30 more
Sep 3, 2020

Alzheimer's Disease Trial in United States (Flortaucipir F18, PET Scan)

Completed
  • Alzheimer's Disease
  • Flortaucipir F18
  • PET Scan
  • Phoenix, Arizona
  • +21 more
Aug 7, 2020

Alzheimer's Disease Trial in United States (Aducanumab (recombinant, fully human anti-Aß IgG1 mAb), Placebo)

Terminated
  • Alzheimer's Disease
  • Aducanumab (recombinant, fully human anti-Aβ IgG1 mAb)
  • Placebo
  • Tucson, Arizona
  • +31 more
Jul 31, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Scottsdale, Arizona
  • +210 more
Jul 1, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +195 more
Jul 1, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab)

Terminated
  • Alzheimer's Disease
  • Newport Beach, California
  • +65 more
Jun 25, 2020

Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia Trial in Worldwide (LMTM)

Terminated
  • Alzheimer's Disease
  • Behavioral Variant Frontotemporal Dementia
  • Phoenix, Arizona
  • +134 more
May 15, 2020

Alzheimer's Disease Trial in Worldwide (RVT-101 35 mg tablets)

Terminated
  • Alzheimer's Disease
  • RVT-101 35 mg tablets
  • Phoenix, Arizona
  • +168 more
Apr 14, 2020

Alzheimer's Disease, Healthy Volunteer Trial in United States (BIIB076, Placebo)

Completed
  • Alzheimer's Disease
  • Healthy Volunteer
  • Hallandale Beach, Florida
  • +7 more
Mar 23, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +85 more
Feb 18, 2020

Alzheimer's Disease Trial in United States ([18F]GTP1)

Completed
  • Alzheimer's Disease
  • New Haven, Connecticut
  • +15 more
Dec 19, 2019

Alzheimer's Disease Trial in Worldwide (Lanabecestat, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +261 more
Nov 19, 2019

Alzheimer's Disease Trial in Worldwide (Lanabecestat)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +132 more
Nov 19, 2019

Alzheimer's Disease Trial in United States (BPN14770, Placebo)

Unknown status
  • Alzheimer's Disease
  • Gilbert, Arizona
  • +40 more
Oct 30, 2019

Alzheimer's Disease Trial in Worldwide (Group 1 ELND005, Group 2 ELND005)

Terminated
  • Alzheimer's Disease
  • Group 1 ELND005
  • Group 2 ELND005
  • Birmingham, Alabama
  • +45 more
Oct 17, 2019

Alzheimer's Disease Trial in Worldwide (ELND005, Placebo)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +69 more
Oct 17, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +192 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +197 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +146 more
Sep 25, 2019

Alzheimer's Disease Trial in Canada, Puerto Rico, United States (Dimebon, Placebo)

Completed
  • Alzheimer's Disease
  • Mobile, Alabama
  • +117 more
Nov 6, 2018

Alzheimer's Disease Trial in Worldwide (RVT-101, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +196 more
Nov 8, 2018

Alzheimer's Disease Trial in Worldwide (Idalopirdine 60 mg)

Completed
  • Alzheimer's Disease
  • Idalopirdine 60 mg
  • Birmingham, Alabama
  • +257 more
Aug 9, 2018

Alzheimer's Disease Trial in United States (Bryostatin 1, Placebo)

Completed
  • Alzheimer's Disease
  • Bryostatin 1
  • Placebo
  • Phoenix, Arizona
  • +28 more
Jun 6, 2018

Alzheimer's Disease Trial in Worldwide (LY2886721, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +33 more
May 16, 2018